Kyle Pedretty, Ph.D.

Dr. Kyle Pedretty is a technical specialist within the firm's Intellectual Property practice group. Kyle is an organic chemist with over nine years of research experience. His research focused across a wide array of topics including strain-release chemistry, covalent inhibitor development, and peptidomimetic design.

As a former Division 1 athlete, Kyle appreciates the significance of a collaborative team mindset and is passionate about applying his chemistry skills to address challenging problems in drug discovery and design. 

Prior to joining the firm, Kyle served as a research scientist at a Florida-area cancer research and treatment center, developing strain-release reagents for installing covalent reactive groups on small molecules. He also served as an Adjunct Professor at the University of South Florida, where he lectured and mentored students in organic chemistry courses. Kyle is a member of the American Chemical Society and also holds a CNPR certification from the National Association of Pharmaceutical Sales Representatives. 

• Co-author, "Five-membered ring systems: pyrroles and benzo analogs," Progress in Heterocyclic Chemistry, September 25, 2022
• Co-author, "Five-membered ring systems: pyrroles and benzo analogs," Progress in Heterocyclic Chemistry, January 2021
• Co-author, "δ-Azaproline and its oxidized variants," Journal of Organic Chemistry, February 2020
• Co-author, "Synthesis and β-sheet propensity of constrained N-amino peptides," Bioorganic & Medical Chemistry Journal, March 2018
• Co-author, "Catalytic Lewis acid phosphorylation with pyrophosphates," Tetrahedron, November 2012